Degrees Pharmaceuticals has received approval from the IRB for a Phase II trial of Arakoda (tafenoquine) for treating chronic babesiosis.

Albuquerque's film industry is poised for a game-changing addition. Discover the latest twist in this high-stakes studio ...

Investigational Review Board (IRB) approval has been granted for the open ... Read our editorial policy to learn more about our process.

United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's regulatory and capital markets ...

DENVER, Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage therapeutic medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on ...

Currently, we are engaged with more than a dozen new medical centers, with seven of these hospitals advancing into the IRB approval process. Additionally, I'm pleased to report that several of our ...

Information related to the IRB submission process. The UB IRB has updated the HRP-503 Template ... Modifications and Continuing Review submissions of currently approved studies will still be accepted ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...